Powered by 
Google Übersetzer
Google Übersetzer
Key market opportunities for the Pergoveris market include increased adoption of IVF procedures and precision hormone therapies, expanded fertility tourism, and rising infertility awareness. Advances in recombinant hormone technologies and patient-friendly injectable formats further drive growth, particularly amid tariff impacts encouraging domestic biologic production.
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Pergoveris Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The Pergoveris market is experiencing significant growth, driven by a range of factors and trends. Historically, the market has benefited from a rise in the diagnosis of gonadotropin deficiencies, the expansion of assisted reproductive clinics, and improvements in IVF success rates. The introduction of recombinant hormone technologies and increased infertility awareness have further fueled growth.
Moving forward, the demand for advanced IVF protocols and precision hormone therapies is expected to rise. The expansion of fertility tourism and patient-friendly injectable formats are also projected to contribute to market growth. Investment in reproductive biotechnology remains strong, alongside a growing focus on precision-controlled fertility treatments and hormone deficiency management.
A major driver of market expansion is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle choices, and conditions like PCOS and endometriosis. Pergoveris plays a crucial role by stimulating ovarian function, aiding women with severe gonadotropin deficiency. According to the WHO, infertility affects roughly 17.5% of the global adult population. As a result, the Pergoveris market is experiencing significant expansion to meet this need.
The rise in IVF adoption is another key factor propelling the Pergoveris market. As parenthood is increasingly delayed, age-related fertility decline is pushing more individuals towards fertility treatments. Pergoveris supports controlled ovarian stimulation, enhancing pregnancy outcomes. Reports indicate a marked increase in IVF cycles and egg freezing activities, illustrating the growing reliance on such treatments.
Leading companies in the Pergoveris market are pursuing regulatory innovations to enhance access, such as engaging in priority-review filings under the FDA CNPV program to expedite approval processes. This program enables faster introduction of innovative treatments while ensuring safety and efficacy. For instance, in October 2025, EMD Serono filed Pergoveris under this program, leveraging a pre-filled Redi-ject pen to simplify dosing and improve patient experience.
Regionally, Europe dominated the Pergoveris market in 2025, while Asia-Pacific is positioned for accelerated growth. The market spans key regions including Asia-Pacific, Western Europe, Eastern Europe, and North America, with significant activity observed in countries like the UK, Germany, China, and the USA.
Global Pergoveris Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
Global Pergoveris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
Global Pergoveris Market Size, Comparisons and Growth Rate Analysis
Global Pergoveris Historic Market Size and Growth, 2020-2025, Value ($ Billion)
Global Pergoveris Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)
Major Trends
Increasing Adoption of Recombinant Hormone Therapies
Rising Demand for Ivf and Art Procedures
Growing Use of Injectable Pen Formulations
Expansion of Precision-Controlled Fertility Treatments
Enhanced Focus on Hormone Deficiency Management
Pergoveris Market Segmentation
Global Pergoveris Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Global Pergoveris Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Global Pergoveris Market, Segmentation by Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Global Pergoveris Market, Segmentation by End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/6fe2ay
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
